NIAMS Scholars

Image of Hanna Kim.

Hanna Kim, M.D.

Hanna Kim received her undergraduate degree from California Institute of Technology (Caltech) and her medical degree from the University of California at Irvine (UCI). She completed residence in Pediatrics at George Washington University / Children’s National Medical Center. She completed a pediatric rheumatology fellowship at Nemours/Alfred I. DuPont Hospital for Children, Children’s National Health System, and NIAMS. She has been awarded the Earl J. Fellow Research Award from the American Academy of Pediatrics, Rheumatology Research Foundation Marshall J. Schiff Memorial Fellow Research Award, and American College of Rheumatology Distinguished Fellow Award. She was subsequently promoted to Lawrence Shulman Scholar in Pediatric Translational Medicine at NIAMS. Her current research interest is pathogenesis and biomarker discovery in juvenile dermatomyositis by comparison with Mendelian autoinflammatory diseases.

 

Image of Laura Lewandowski.

Laura Lewandowski, M.D.

Laura Lewandowski received her undergraduate degree from the College of the Holy Cross in Worchester, Massachusetts, and her medical degree from Pennsylvania State University College of Medicine. She completed pediatric residency training at the University of Massachusetts Medical Center, where she also served as a chief resident in pediatrics, and developed a program in Global Health training. She completed a combined four-year pediatric rheumatology/ global health fellowship at Duke University Medical Center, during which she characterized a pediatric lupus patient cohort in South Africa. She holds a Masters in Global Health from Duke University, as well. She was awarded a Fogarty Global Health Fellowship and a Lupus Foundation Early Career award for her work with pediatric lupus patients in South Africa. In 2015, she joined the NIAMS under Dr. Mariana Kaplan as a Lawrence Shulman Scholar in Translational Medicine. Her current research interests include clinical and translational research in pediatric systemic lupus erythematosus (SLE), with a focus on markers of inflammation and gene expression profiling for pediatric SLE patients in varied cohorts around the world.

 

 

This page last reviewed on February 10, 2020